Memory, coping strategies and resilience immediately following a loss have been shown to predict the path of a bereaved person’s grief according to new research. The study, published in the Journal of Consulting and Clinical Psychology last month, also suggested that clinical intervention in the first months following a loss may help individuals to better…
Large scale analysis of antipsychotics could improve outcomes for schizophrenia patients
Results of a network meta-analysis published in The Lancet this month will aid clinicians in balancing the risks and benefits of the antipsychotic drugs they are prescribing to treat schizophrenia. Schizophrenia is one of the most common psychiatric disorders in adults worldwide – one in 100 people globally are affected over a lifetime.
Help us improve how research interacts with electronic health records
Join our focus group to help develop a new research project! About the research The anonymous use of health records for mental health research has the potential to lead to great breakthroughs to improve the lives of patients. A key step in making this data available for research is the ‘de-identification’ of information in health…
Preventing dementia – join our focus group for a new research project
Are you interested in dementia research? Do you have experience of caring for or supporting someone with dementia? Do you want to share your views and experience to develop a research project? About the research Dementia is a complex disease. There is currently no cure, only treatments that temporarily reduce symptoms. In spite of this,…
Oxford Short Course in Experimental Medicine for Mental Health – OxCEMM
This new course ran for the first time in January 2019, with an engaging and thought-provoking programme of talks, tours of facilities and group discussions. Feedback from participants was uniformly excellent. Applications for the January 2020 course are open until Friday 4th October 2019 . The Oxford Short Course in Experimental Medicine for Mental Health…
New study shows close monitoring is essential to ensure safety of ketamine for depression
Patients, carers and advocates say better evidence is needed on the safety of ketamine for depression after long-term use, and that those prescribed it must be closely monitored. These are the results of a study undertaken as part of a collaboration between the NIHR Oxford Health Biomedical Research Centre and NIHR Maudsley Biomedical Research Centre….
